OBJECTIVE: The objective of the study was to evaluate angiogenic factors for the prediction of preeclampsia in high-risk women. STUDY DESIGN: We collected serial serum specimens from 94 women at high preeclampsia risk between 22 and 36 weeks\u27 gestation. Soluble fms-like tyrosine kinase-1 (sFlt1) and placental growth factor (PlGF) were measured by enzyme-linked immunosorbent assay. RESULTS: Mean serum sFlt1 and the sFlt1/PlGF ratio were higher in subjects who developed early-onset (less than 34 weeks) preeclampsia, as compared with subjects without preeclampsia, from 22 weeks gestation onward. In subjects who developed late-onset (34 weeks or later) preeclampsia, sFlt1 was significantly increased after 31 weeks\u27 gestation. The sFlt1/Pl...
BACKGROUND: Differences in circulating concentrations of antiangiogenic factors sFlt1 and soluble en...
OBJECTIVE: To determine if maternal serum angiogenic factors predict maternal and neonatal complicat...
OBJECTIVE: To determine if maternal serum angiogenic factors predict maternal and neonatal complicat...
OBJECTIVE: The objective of the study was to evaluate angiogenic factors for the prediction of preec...
OBJECTIVE: Chronic hypertension, pregestational diabetes mellitus, history of prior preeclampsia and...
OBJECTIVE: Chronic hypertension, pregestational diabetes mellitus, history of prior preeclampsia and...
Objective: Chronic hypertension, pregestational diabetes mellitus, history of prior preeclampsia and...
Objective: Chronic hypertension, pregestational diabetes mellitus, history of prior preeclampsia and...
International audienceObjectives. - Despite its simple definition, preeclampsia can have variable an...
OBJECTIVE: Several conditions are associated with increased preeclampsia (PE) risk. Whether altered ...
Objective: To evaluate angiogenic risk factor parameters in women with a history of severe, very ear...
OBJECTIVE: Several conditions are associated with increased preeclampsia (PE) risk. Whether altered ...
Background: The etiological nature of preeclampsia is heterogeneous. The use of biomarkers indices i...
OBJECTIVE: We aimed to investigate how maternal serum soluble Fms-like kinase 1 (sFlt-1), placental ...
OBJECTIVE: We aimed to investigate how maternal serum soluble Fms-like kinase 1 (sFlt-1), placental ...
BACKGROUND: Differences in circulating concentrations of antiangiogenic factors sFlt1 and soluble en...
OBJECTIVE: To determine if maternal serum angiogenic factors predict maternal and neonatal complicat...
OBJECTIVE: To determine if maternal serum angiogenic factors predict maternal and neonatal complicat...
OBJECTIVE: The objective of the study was to evaluate angiogenic factors for the prediction of preec...
OBJECTIVE: Chronic hypertension, pregestational diabetes mellitus, history of prior preeclampsia and...
OBJECTIVE: Chronic hypertension, pregestational diabetes mellitus, history of prior preeclampsia and...
Objective: Chronic hypertension, pregestational diabetes mellitus, history of prior preeclampsia and...
Objective: Chronic hypertension, pregestational diabetes mellitus, history of prior preeclampsia and...
International audienceObjectives. - Despite its simple definition, preeclampsia can have variable an...
OBJECTIVE: Several conditions are associated with increased preeclampsia (PE) risk. Whether altered ...
Objective: To evaluate angiogenic risk factor parameters in women with a history of severe, very ear...
OBJECTIVE: Several conditions are associated with increased preeclampsia (PE) risk. Whether altered ...
Background: The etiological nature of preeclampsia is heterogeneous. The use of biomarkers indices i...
OBJECTIVE: We aimed to investigate how maternal serum soluble Fms-like kinase 1 (sFlt-1), placental ...
OBJECTIVE: We aimed to investigate how maternal serum soluble Fms-like kinase 1 (sFlt-1), placental ...
BACKGROUND: Differences in circulating concentrations of antiangiogenic factors sFlt1 and soluble en...
OBJECTIVE: To determine if maternal serum angiogenic factors predict maternal and neonatal complicat...
OBJECTIVE: To determine if maternal serum angiogenic factors predict maternal and neonatal complicat...